August 1, 2016 – HighTide Biopharmaceutical and ProSciento Inc., announced a partnership focused on developing therapies for diabetes and nonalcoholic fatty liver disease, according to a press release.
August 1, 2016 – HighTide Biopharmaceutical and ProSciento Inc., announced a partnership focused on developing therapies for diabetes and nonalcoholic fatty liver disease, according to a press release.
